Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma

Published:2012-03-03 Issue:5 Volume:87 Page:479-483
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Kim Ji-Won,Lee Hyun Jung,Yi Hyeon Gyu,Kim Byung-Su,Bang Soo-Mee,Kim Jin Seok,Kim Inho,Yoon Sung-Soo,Lee Jong Seok,Kim Chul Soo,Park Seonyang,Kim Byoung Kook

Publisher

Wiley

Subject

Hematology

Reference30 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-a groupe d'Etude des lymphomes de l'Adulte study;Haioun;J Clin Oncol,2000

3. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support;Milpied;N Engl J Med,2004

4. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma;Wang;Bone Marrow Transplant,2004

5. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies;Alessandrino;Bone Marrow Transplant,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development status of 30 MeV cyclotron-based neutron source in Korea;EPJ Web of Conferences;2024

2. Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma;Leukemia & Lymphoma;2023-01-19

3. A Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients;Indian Journal of Hematology and Blood Transfusion;2021-05-05

4. The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”;Istanbul Medical Journal;2021-04-22

5. Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL);Bone Marrow Transplantation;2020-04-17